PeterNWeissmanMD

Endocrinology • Miami, FL

Diabetes, Lipid Metabolism

Associate Clinical Professor of Medicine, University Miami School of Medicine

Join to view full profile

Dr. Weissman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weissman's full profile

Already have an account?

Office
7867 N Kendall Dr
Suite 80
Miami, FL 33156
Phone+1 305-595-0777

Fax+1 305-412-9255

Education & Training

University of MichiganFellowship, Endocrinology, Diabetes, and Metabolism, 1970 - 1972
University of MichiganResidency, Internal Medicine, 1970 - 1972
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1967 - 1968
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1966 - 1967
New York University School of MedicineClass of 1966

Certifications & Licensure

MI State Medical License Current
FL State Medical License 1973 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:South Florida Castle Connolly, 2012
SouthFloridaCEO: Top Doctors Castle Connolly, 2002-2003
Miami Metro City Guide: Top Doctors Castle Connolly, 2001
Top Doctors: Florida Castle Connolly, 2000
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACE) American Association of Clinical Endocrinology
Join now to see all

Clinical Trials

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics Start of enrollment: 2011 Mar 01
Terminated
Phase 3
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Completed
Phase 3

Publications & Presentations

PubMed

18 citations
Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy
Philip Home, Bo Ahrén, Jane E.B. Reusch, Marc Rendell, Peter N. Weissman
Diabetes Research and Clinical Practice. 2017-09-01
104 citations
HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin wit...
Peter N. Weissman, Molly C. Carr, June Ye, Deborah T. Cirkel, Murray Stewart
Diabetologia. 2014-09-11
5 citations
Clinical practice effect of rosiglitazone discontinuation on glycemic control.
Etta L. Fanning, Peter N Weissman, Laura Menditto
Endocrine Practice. 2009-04-01

Professional Memberships

American Association of Clinical Endocrinologists - AACE
Fellow